Investigating Intellia’s CRISPR therapy NTLA-2002 in development for the treatment of swelling attacks in hereditary angioedema (HAE).Ticker(s): NTLA
Institution: University of Tennessee
- Associate Professor and Director of Allergy & Immunology training at the University of Tennessee.
- Manages 3 patients with Hereditary angioedema.
- Research focuses on food allergy, anaphylaxis, primary immune deficiency, and drug allergy.
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.